Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Nippon Shinyaku synthesizes vitamin D3 antedrug

Sep. 29, 2011

Denosumab shows long-term safety and efficacy in postmenopausal osteoporosis

Sep. 29, 2011

Long-term data presented on LB-03002 in children with growth hormone deficiency

Sep. 29, 2011

Preliminary findings from IMPACT study made available

Sep. 29, 2011

Recombinant measles vector-based HIV-1 vaccine evaluated in primates

Sep. 29, 2011

Preclinical and first-in-human data presented on NDV-3 candidiasis vaccine

Sep. 29, 2011

Glycopyrrolate formulations show efficacy in randomized phase II trials in COPD

Sep. 28, 2011

Progenics discloses preclinical data on humanized MAbs targeting C. difficile toxins

Sep. 28, 2011

Phase I/II trial investigates polyepitope DNA vaccine in metastatic melanoma

Sep. 28, 2011

Taliglucerase alfa assessed in Gaucher's disease under French AUT program

Sep. 28, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 28, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 28, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...